Atransferrinemia is a very rare disorder, which is caused by a deficiency of the protein
transferrin. No regular treatment is available for these patients. The objective of this
study is to investigate the pharmacokinetics, efficacy and safety of Apotransferrin
replacement therapy in atransferrinemia patients.